NextPlat NXPL
NASDAQ NXPL
$9.13 -0.30 (-3.18%)
At close: Sep 4, 2026 · 4:00 PM EDT

NextPlat (NXPL) Research & Development (2011 - 2013)

NextPlat's (NXPL) quarterly Research & Development came in at $5000.0 in Q1 2013, down 54.33% year-over-year from $10949.0 in Q1 2012, and down 94.03% quarter-over-quarter from $83701.0 in Q3 2012.

Analysis

NextPlat (NXPL) Research & Development (2011 - 2013) Analysis & Trends

NextPlat (NXPL) has reported Research & Development for 3 consecutive years, with $5000.0 the latest figure, recorded in Q1 2013.

  • On a quarterly basis, Research & Development fell 54.33% year-over-year to $5000.0 in Q1 2013; TTM through Mar 2013 was $296549.0, a 77.24% increase from a year earlier, with the FY2012 full-year figure at $115832.0, down 25.92% from the prior year.
  • Research & Development was $5000.0 for Q1 2013 at NextPlat, down from $83701.0 in the prior quarter.
  • Over five years, Research & Development peaked at $196899.0 in Q2 2012 and troughed at $5000.0 in Q1 2013.
  • A 3-year average of $64701.7 and a median of $61620.0 in 2011 frame the typical range for Research & Development.
  • Across the five-year window, Research & Development soared 219.54% in 2012 and slumped 54.33% in 2013, its largest moves.
  • Over 3 years, Research & Development stood at $31451.0 in 2011, then surged by 166.13% to $83701.0 in 2012, then tumbled by 94.03% to $5000.0 in 2013.
  • The last three Research & Development figures came in at $5000.0 (Q1 2013), $83701.0 (Q3 2012), and $196899.0 (Q2 2012), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 970.00 Mn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 248.30 Mn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 60.90 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 39.02 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 173.00 Mn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 14.75 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn -21.86 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 22.16 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn 10.66 Mn
10 NextPlat 24.77 Mn 12.93 Mn 4.69 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2013 5,000.00
Sep 30, 2012 83,701.00
Jun 30, 2012 196,899.00
Mar 31, 2012 10,949.00
Dec 31, 2011 31,451.00
Sep 30, 2011 63,292.00
Jun 30, 2011 61,620.00